153 WPPh (Hydrochlorothiazide and methyldopa 25 mg / 250 mg)
Pill imprint 153 WPPh has been identified as Hydrochlorothiazide and methyldopa 25 mg / 250 mg.
Hydrochlorothiazide/methyldopa is used in the treatment of high blood pressure and belongs to the drug class antiadrenergic agents (central) with thiazides. Risk cannot be ruled out during pregnancy. Hydrochlorothiazide/methyldopa 25 mg / 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 153 WPPh
- Strength:
- 25 mg / 250 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents (central) with thiazides
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- West Point
More about hydrochlorothiazide/methyldopa
Consumer resources
- Methyldopa/hydrochlorothiazide
- Hydrochlorothiazide and methyldopa
- Methyldopa and hydrochlorothiazide (Advanced Reading)
- Other brands: Aldoril, Aldoril 25, Aldoril 15
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
